4.7 Article

Peptide-Based Nanoparticles to Rapidly and Efficiently Wrap 'n Roll siRNA into Cells

期刊

BIOCONJUGATE CHEMISTRY
卷 30, 期 3, 页码 592-603

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.8b00776

关键词

-

资金

  1. French National Research Agency [ANR-10-INBS-04]
  2. Fondation pour la Recherche Medicale [DBS 20140930769]
  3. Labex TRAIL TARGLIN [ANR-10-LABX-57]
  4. Centre National de la Recherche Scientifique

向作者/读者索取更多资源

Delivery of small interfering RNA (siRNA) as a therapeutic tool is limited due to critical obstacles such as the cellular barrier, the negative charges of the siRNA molecule, and its instability in serum. Several siRNA delivery systems have been constructed using cell-penetrating peptides (CPPs) since the CPPs have shown a high potential for oligonucleotide delivery into the cells, especially by forming nanoparticles. In this study, we have developed a new family of short (Miner or 16mer) tryptophan-(W) and arginine-(R) rich Amphipathic Peptides (WRAP) able to form stable nanoparticles and to enroll siRNA molecules into cells. The lead peptides, WRAP1 and WRAPS, form defined nanoparticles smaller than 100 nm as characterized by biophysical methods. Furthermore, they have several benefits as oligonucleotide delivery tools such as the rapid encapsulation of the siRNA, the efficient siRNA delivery in several cell types, and the high gene silencing activity, even in the presence of serum. In conclusion, we have designed a new family of CPPs specifically dedicated for siRNA delivery through nanoparticle formation. Our results indicate that the WRAP family has significant potential for the safe, efficient, and rapid delivery of siRNA for diverse applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Analytical

Determination of the Rituximab Binding Site to the CD20 Epitope Using SPOT Synthesis and Surface Plasmon Resonance Analyses

Laure Bar, Christophe Nguyen, Mathieu Galibert, Francisco Santos-Schneider, Gudrun Aldrian, Jerome Dejeu, Remy Lartia, Liliane Coche-Guerente, Franck Molina, Didier Boturyn

Summary: Antibodies are not only important for clinical diagnostics and biopharmaceutical analysis, but also as drugs for treating various diseases. The identification of antibody-epitope binding sites, particularly for designing monoclonal antibody mimics like rituximab, is crucial for medical and bioanalytical applications. Rituximab, a monoclonal antibody used to treat cancers and autoimmune disorders, binds to targeted cells via the recognition of the CD20 epitope, with its binding area located on the surface of rituximab.

ANALYTICAL CHEMISTRY (2021)

Article Materials Science, Multidisciplinary

Combination of MRI-Guided High-Intensity Focused Ultrasound and Bioluminescent Biological Systems to Assess Thermal Therapies for Tumor and Tumor Microenvironment

Pauline Jeanjean, Dounia El Hamrani, Coralie Genevois, Bruno Quesson, Franck Couillaud

Summary: This study presents an integrated technology for assessing in vivo anticancer treatments in mice, using different heating conditions. Bioluminescence imaging is used to evaluate the physiological response of tumor and tumor microenvironment to heat treatment induced by magnetic resonance-guided high-intensity focused ultrasound.

ADVANCED MATERIALS TECHNOLOGIES (2022)

Article Multidisciplinary Sciences

An allosteric HTRA1-calpain 2 complex with restricted activation profile

Juliana Rey, Maike Breiden, Vanda Lux, Anika Bluemke, Maike Steindel, Kamilla Ripkens, Bastian Moellers, Kenny Bravo Rodriguez, Prisca Boisguerin, Rudolf Volkmer, Joel Mieres-Perez, Tim Clausen, Elsa Sanchez-Garcia, Michael Ehrmann

Summary: This study reports a novel and reversible mechanism of protease activation, where an inactive protease serves as the activator. This mechanism involves the formation of an allosteric complex between HTRA1 and calpain 2, and exhibits activity only towards specific conformations of substrates. These findings have important implications for understanding protein quality control and potential side effects of drug modulation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Pharmacology & Pharmacy

Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide

Quentin Seisel, Israpong Lakumpa, Emilie Josse, Eric Vives, Jessica Varilh, Magali Taulan-Cadars, Prisca Boisguerin

Summary: Therapeutic peptides have regained interest as they can address unmet medical needs and can be an excellent complement to pharmaceutic small molecules and other macromolecular therapeutics. In this study, the optimization of a peptidyl inhibitor and the screening of cell-penetrating peptides resulted in the identification of an optimal peptide for CFTR stabilization. Using this peptide, an additive increase in CFTR amount was observed when combined with a small-molecule treatment. This finding is significant for the development of CFTR-stabilizing peptides as additional treatments for CF patients.

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy

Ruben Faria, Milan Paul, Swati Biswas, Eric Vives, Prisca Boisguerin, Angela Sousa, Diana Costa

Summary: Mitochondria have their own genome and mutations in mitochondrial DNA can lead to various diseases. Developing a gene delivery system specifically targeting mitochondria is crucial for mitochondrial gene therapy. This study compared polymer- and peptide-based systems and found that peptides have a better capability to complex with DNA, forming smaller particles suitable for cellular transfection and mitochondrial gene therapy.

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy

Ana Raquel Neves, Tania Albuquerque, Ruben Faria, Ana M. Goncalves, Cecilia Santos, Eric Vives, Prisca Boisguerin, Luis A. Passarinha, Angela Sousa, Diana Costa

Summary: Despite progress in cancer diagnosis and treatment, glioblastoma remains the most lethal brain tumor. Gene therapy focused on non-viral vectors, such as transferrin (Tf), has been developed as a promising approach. In this study, a cell-penetrating peptide (WRAP5) targeting Tf was used to condense tumor suppressor p53-encoding plasmid DNA (pDNA), forming nanocomplexes. These complexes showed efficient cellular internalization, gene expression, and decreased viability of glioblastoma cells.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

The Difference in Structural States between Canonical Proteins and Their Isoforms Established by Proteome-Wide Bioinformatics Analysis

Zarifa Osmanli, Theo Falgarone, Turkan Samadova, Gudrun Aldrian, Jeremy Leclercq, Ilham Shahmuradov, Andrey Kajava

Summary: Alternative splicing is an important mechanism for generating protein diversity in cells. However, there is still a lack of structural data on alternative protein isoforms, as experimental studies typically focus on canonical proteins. In recent years, advances in bioinformatics tools and the development of the AlphaFold program have allowed for the modeling of high-confidence structures of isoforms. In this study, in silico analysis of 58 eukaryotic proteomes was performed, revealing differences in signal peptides, transmembrane regions, and tandem repeat regions between isoforms and canonical counterparts, potentially impacting protein function and cellular localization.

BIOMOLECULES (2022)

Article Cell & Tissue Engineering

PPARβ/δ-Interfering Peptide Enhanced Mesenchymal Stromal Cell Immunoregulatory Properties

Gautier Tejedor, Prisca Boisguerin, Eric Vives, Christian Jorgensen, Jerome Guicheux, Claire Vinatier, Claire Gondeau, Farida Djouad

Summary: An interfering peptide was designed and synthesized to enhance the immunoregulatory properties of mesenchymal stem cells.

STEM CELLS INTERNATIONAL (2022)

Article Multidisciplinary Sciences

Mycobacterium abscessus alkyl hydroperoxide reductase C promotes cell invasion by binding to tetraspanin CD81

Jona Karam, Fabien P. Blanchet, Eric Vives, Prisca Boisguerin, Yves-Marie Boudehen, Laurent Kremer, Wassim Daher

Summary: It has been discovered that neutralizing anti-CD81 antibodies and deletion of the large extracellular loop (LEL) of CD81 significantly reduce the uptake of Mab by macrophages. Saturation of Mab with soluble GST-CD81-LEL or CD81-LEL-derived peptides also decreases the internalization of the bacteria. The study unveils AhpC as a major interactant of CD81-LEL, and pre-exposure of macrophages with soluble AhpC inhibits mycobacterial uptake while overexpression of AhpC in Mab enhances its internalization. These findings highlight the previously unexplored role of CD81/AhpC in promoting the uptake of pathogenic mycobacteria by host cells.

ISCIENCE (2023)

Article Biochemistry & Molecular Biology

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib

Salome Ruiz-Demoulin, Eva Trenquier, Sanaa Dekkar, Sebastien Deshayes, Prisca Boisguerin, Cesar Serrano, Pascal de Santa Barbara, Sandrine Faure

Summary: Gastrointestinal stromal tumor (GIST) is mainly caused by a KIT receptor tyrosine kinase oncogenic mutation. Targeting KIT using tyrosine kinase inhibitors provides benefit, but resistance eventually develops. This study shows that LIX1 is upregulated in response to imatinib or sunitinib treatment in GIST cells and silencing LIX1 enhances the anti-tumor effect of imatinib by inhibiting MAPK signaling reactivation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Pharmacology & Pharmacy

Delivery Systems for Mitochondrial Gene Therapy: A Review

Ruben Faria, Prisca Boisguerin, Angela Sousa, Diana Costa

Summary: Mitochondria are crucial cellular organelles responsible for energy production in cells, and mutations in their DNA (mtDNA) can lead to various diseases. Mitochondrial gene therapy is a promising strategy to address these disorders. Developing efficient mtDNA-based delivery systems to target and transfect mammalian mitochondria is an exciting area of research that can contribute to restoring normal mitochondrial function.

PHARMACEUTICS (2023)

暂无数据